Insiders Seeing Green With VRTX At New 52-Week High

In trading on Friday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) touched a new 52-week high of $239.82/share. That's a 35.98% rise, or $63.46 per share from the 52-week low of $176.36 set back on 10/06/2021. That means at today's intraday high, any investor who purchased VRTX stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, VRTX has seen 2 different instances of insiders buying over the trailing six month period.

Purchased Insider Title Shares Price/Share Value
08/02/2021 Bruce I. Sachs Director 15,000 $197.91 $2,968,650.00
08/19/2021 Reshma Kewalramani CEO & President 10,000 $195.65 $1,956,491.60

The chart below shows where VRTX has traded over the past year, with the 50-day and 200-day moving averages included.

Vertex Pharmaceuticals, Inc. Moving Averages Chart

In afternoon trading on Friday, VRTX shares are changing hands at $239.50/share, slightly below the new 52-week high.

Ten Bargains You Can Buy Cheaper Than The Insiders Did »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.